BIOCHEMICAL AND BIOPHYSICAL RESEARCHCOMMUNICATIONS Pages 503-508
Vol. 155, No.l, 1988 August 30, 1988
AFFINITY
GELS
FOR PURIFICATION
RETINOID-SPECIFIC
Hiroyuki
Kagechika,
BINDING
Yuichi
Hashimoto,
Koichi
Faculty
of P h a r m a c e u t i c a l 7-3-1
Hongo,
OF
PROTEIN
(RSBP)
Emiko
Kawachi
and
Shudo
Sciences,
Bunkyo-ku,
University
Tokyo
113,
of T o k y o
Japan
Received June 20, 1988
Retinoids are d e f i n e d as c o m p o u n d s which elicit specific biological effects such as control of cell growth and cell d i f f e r e n t i a t i o n b y b i n d i n g to a s p e c i f i c r e c e p t o r . R e c e n t l y , we d e m o n s t r a t e d the p r e s e n c e of a p r o t e i n (RSBP) w h i c h s a t i s f i e s the c r i t e r i a for t h e r e t i n o i d r e c e p t o r . F o r p u r i f i c a t i o n of RSBP, w e p r e p a r e d two t y p e s of a f f i n i t y g e l s w i t h r e t i n o i d a l l i g a n d s (GelAm and Gel-Ch) based on synthetic ret i n o b e n z o i c acids which p--ossess v e r y p o t e n t retinoidal activities. R S B P in t h e c r u d e fraction extracted from cultured cells could be purified about 300-fold by affinity column chromatography using these affinity gels. © 1988 Academic Press, Inc.
Retinoids controlling believed
that
(retinoidal though not
the
well
receptor
new
Among
molecular
drawing
and
retinoids
by
been
effects class
the s y n t h e s i z e d
a
the
retinoidal
acid
for
(RA),
synthetic
reported
the
relationships acids. S - ~
4-(5,6,7,8-tetrahydroacid
(Am80) ~
(E)-4-[3-(3,5-di-tert-butylphenyl)-3-oxo-l-propenyi]benzoic
acid
(Ch55) ~
compounds to
are
retinoid
many
we
5,5,8,8-tetramethyl-2-naphthalenylcarbamoyl)benzoic and
is
effects
a
retinobenzoic
acids,
It
activities such
and
Recently,
retinoids,
retinobenzoic
agents
r e c e p t o r , I-4~
and s t r u c t u r e - a c t i v i t y
of
as
biological
specific
ligand
r e p o r t e d . I, z~
biological structural
specific to
classical
all-trans-retinoic
have
the
of
attention
d i f f e r e n t i a t i o n . ', 2'
binding
mechanisms A
much
cell
elicit
activities)
is
synthesis, a
been
growth
understood.
retinoids
of
have
cell
the
should
biological
more
assay
potent
has
been
potent
systems)
retinoidal
their biological
r e c e p t o r . 3, 4~
receptor show
quite
also eliciL
retinoid
retinoid (which
possess
One
of
the
CRABP. ~, 2~
to C R A B P
503
effects
than
with much
These
by binding
candidates
However,
bioactivities
bind
activities.
for
Am80 RA lower
such
and
in
a
Ch55
various
affinity
0006-291X/88 $1.50 Copyright © 1988 by Academic Press, Inc. All rights of reproduction in any form reserved.
Vol. 155, No. 1, 1988
than
RAg-~
estimated true
;
the
to be
retinoid
possess
affinities
1/80 and
recently,
to
amount
Ch55 w i t h
very high
protein
receptor,
is a p r o t e i n
and
reported
named
steroid cloned gate
genes
were
and to reveal essential In (Figs. partial
1
this
acid
we
based
on
the
weight
which
receptor acid
mechanism
describe new-type
of R S B P
of
possess-
10 l° M-I ). 14~ and E v a n s I ~
on the b a s i s
of
should
resemble
of the p r o d u c t s
of t h e i r
of c l o n e d
To
genes
of r e t i n o i d a l
the
and
(association
50 kDa. ~5-~7~
products
protein
fraction,
o f 95 kDa,
gene
no and
retinoid
binding
receptor
weights
Am80
m a n n e r . 14~
true
a n d Ch55
in
high
possess RA,
of C h a m b o n ~5. ~6~
to be a r o u n d these
to to
competitive for
Am80
a n d to c h a r a c t e r i z e
paper,
binds
are of the o r d e r
retinoic
reported between
reported
that
for RA,
The m o l e c u l a r
purification
Materials
The
of a p r o t e i n
in the n u c l e a r
the g r o u p s
the m o l e c u l a r
2)
is )
molecular
retinoids
the
to i s o l a t e
and
were
(which possesses
retinoid-specific
of r e t i n o i c
that
relation
CRABP
compounds
the p r e s e n c e
criteria
affinity
these
receptors.
the
for
r e s p e c t i v e l y . 9~ the
line H L - 6 0
predominantly
an a p p a r e n t
a cloning
assumption
Ch55
all
in a m u t u a l l y
the
O n the o t h e r hand,
the
and
to
which
affinity
binding
toward
cell
C R A B P 9. 12, ~
exists
with
ing v e r y h i g h constants
of
was
RSBP
bind
we d e m o n s t r a t e d
leukemia
satisfies
and
(RSBP). 14~
should
retinoids,
detectable
This
Am80
of that of RA,
a c t i v i t y 4~
promyelocytic
response
of
1/530
receptor
retinoidal Very
human
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
investia n d RSBP,
action,
it is
RSBP. synthesis
of
retinobenzoic
b y use of the p r e p a r e d
affinity acids,
gels
and
affinity
the
gels.
and M e t h o d s
S y n t h e s i s of the A f f i n i t y L i g a n d 3 (Fig. I): 5,6,7,8-Te-t-rahydro-5,5,8,8-tetramethyl-2-naphthoic a c i d (I, 1.512 g) w a s c o n v e r t e d to the a c i d c h l o r i d e b y thionyl c h l o r i n e treatment, and was condensed with methyl p-aminosalicylate (1.08 g) in the p r e s e n c e of a c a t a l y t i c a m o u n t of 4 - d i m e t h y l a m i n o p y r i d i n e in a m i x t u r e of d r y b e n z e n e (30 ml) a n d p y r i d i n e (3 ml) to g i v e the a m i d e c o m p o u n d 2 in the y i e l d of 64.6% (11.6 g, mp. 2 2 7 . 5 - 2 2 8 . 0 ~ ). The compou-nd 2 (0.5 g) w a s t r e a t e d w i t h s o d i u m h y d r i d e (NaH) in d r y d i m e t h y l f o r m a m i d e ( 5 ml), a n d t h e n m i x e d w i t h BrCHzCHzCHzNHCOOCH2Ph (0.44 g). The m i x t u r e w a s s t i r r e d at r o o m temperature for 15 hr. The protected affinity ligand thus o b t a i n e d (yield: 50.8%) w a s d e p r o t e c t e d w i t h p o t a s s i u m h y d r o x i d e ( h y d r o l y s i s of the e s t e r group, yield: 93.5%) a n d t h e n w i t h trifluoroacetic acid (CF3COOH; debenzyloxycarbonylation) to give a f f i n i t y l i g a n d 3 in the y i e l d of 68.1%. S y n t h e s i s of the--Affinity L i g a n d 7 (Fi~. i): 5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-2-naphthylmethylk e t o n e (4, 36.8 g) was h e a t e d w i t h m - c h l o r o p e r b e n z o i c a c i d (mCPBA, 45 g) in--chloroform (200 ml) for s e v e r a l h o u r s to g i v e c o m p o u n d 4 in the y i e l d of 87.6% (34.5 g). C o m p o u n d 5 w a s h e a t e d at 130140 ~ with aluminum chloride (AICI~, 37--g) to g i v e acetylrearranged product, 5,6,7,8-tetrahydro-3-hydroxy-5,5,8,8-tetra-
504
Vol. 155, No. 1, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
O ~COOCH3
2)
~
c°°cH3
2
H2N" Y -OH I) NaH 2) 3) BrCH2CH2CH2NHCOOCH2Ph KOH )
O /~COOH ~'V~OCH2CH2CH2NH2
4) CF3COOH
m
ococ
i
2
1) Nail 2) BrCH2CH2CH2NHCOOCH2Ph 3) OHC ~
c
COOCH3
s
0
CH2CH2CH2NH2 |
>
~
4) CF3COOH
C
O
O
H
0 7
Fig. i.
Synthesis of affinity ligands
3 and 7
methyl-2-naphthylmethylketone (6) in the y i e l d of 77.7% (48.2 g). The h y d r o x y l g r o u p of 6 (2.532 g) was a l k y l a t e d w i t h B r C H z C H z C H 2 N H C O O C H z P h by the m e t h o d d e s c r i b e d a b o v e to g i v e the or__tho-alkoxy k e t o n e in the y i e l d of 83.6% (3.70 g). The aldol c o n d e n s a t i o n of this ketone(2.0 g) w i t h terephthalaldehydic acid methyl ester (0.75 g) in a m i x t u r e of 2 N s o d i u m h y d r o x i d e (5 ml) and e t h a n o l (30 ml) g a v e p r o t e c t e d a f f i n i t y l i g a n d 7, w h i c h was d e p r o t e c t e d by r e f l u x i n g in C F 3 C O O H to g i v e a f f i n i t y i T g a n d 7. P r e p a r a t i o n of the A f f i n i t y Gels A m and Ch (F~g~2): The N - h y d r o x y s u c c i n i m i d e e s t e r of a g a r o s e (Affi-Gel i0) was obtained from Bio-Rad Laboratories. The gel (2 ml in i s o p r o p a n o l ) was w a s h e d t h r e e times w i t h 2 ml of d i o x a n e a n d was r e s u s p e n d e d in 2 ml of d i o x a n e . To this suspension, ligand 3 or l i g a n d 7, p r e p a r e d as d e s c r i b e d above, and t r i e t h y l a m i n e ~ 1 2 . 5 ~ i) w e r e a d d e d at 25 °C and r e a c t e d for 2 hr. T h e n the u n r e a c t e d Nhydroxysuccinimide e s t e r w a s b l o c k e d by t r e a t m e n t w i t h 0.1 ml of 1 M e t h a n o l a m i n e for 1 hr. The m i x t u r e was d i l u t e d by a d d i t i o n of dioxane (6 ml), and c e n t r i f u g e d (2000 rpm x 4 min), and then decanted. The gel was w a s h e d s u c c e s s i v e l y w i t h dioxane, e t h a n o l and p h o s p h a t e b u f f e r e d s a l i n e (PBS; 136.9 m M NaCI, 2.68 m M KCI, 8.10 m M NazHPO4, 1.47 m M KHzPO4, 0.9 m M CaCI2, 0.49 m M MgCI2), and stocked in PBS containing 0.02% sodium azide at 4 °C . The coupling efficiencies w e r e e s t i m a t e d from U V a b s o r p t i o n m e a s u r e ments. E x t r a c t i o n of R S B P from C u l t u r e d H L - 6 0 Cells: HL-60 cells were cultured, collected and washed as described p r e v i o u s l y . ~4) The cell p e l l e t was homogenized and f r a c t i o n a t e d as d e s c r i b e d p r e v i o u s l y TM e x c e p t that the h o m o g e n i z 505
Vol, 155, No. 1, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
COOH
f
Gel-Am
(CH2)3NHCO(CH2)2CONH(CH2)2NHCOCH20 <
~
COOH
0 Gel-Ch (A = agarose) Fig.
2.
Structures
of affinity
gels,
Gel-~ra and G e l - C h
ing b u f f e r w a s c h a n g e d to PBS c o n t a i n i n g 20 m M Tris (pH 8.0), 0.6 M KCI, 1 m M d i t h i o t h r e i t o l (DTT), 20 m M m o l y b d a t e (Na2MoO4) and a p r o t e a s e i n h i b i t o r c o c k t a i l (PIC: 1 m M p h e n y l m e t h y l m e t h a n e s u l f o n y l f l u o r i d e , 0.1 m g / m l b a c i t r a c i n , 0.1 m M leupeptin, i~ g/ml p e p s t a t i n , 0.i m g / m l a p r o t i n i n a n d 1.5 n ~ EDTA). The a m o u n t of p r o t e i n was e s t i m a t e d b y the C o o m a s s i e b l u e m e t h o d as d e s c r i b e d by B r a d f o r d . TM The a m o u n t of R S B P w a s e s t i m a t e d b y f i l t e r b i n d i n g a s s a y of the s a m p l e s i n c u b a t e d w i t h t r i t i u m - l a b e l e d r e t i n o i d s [ 3 H - A m 8 0 (65 C i / ~ n o l e ) , ~ H - C h 5 5 (20 C i / m m o l e ) or ~ H - R A (50 C i / m m o l e ) ] in the p r e s e n c e o r a b s e n c e of e x c e s s a m o u n t s of c o l d r e t i n o i d s (Am80, Ch55 o r RA) at 4 ~ as d e s c r i b e d p r e v i o u s l y . L4~ Z H - A m 8 0 and 3 H - C h 55 w e r e prepared by Amersham. 3H-RA was purchased from NEN Research Products. P a r t i a l P u r i f i c a t i o n of R S B P U s i n g A f f i n i t y Gel A m o r Ch A f f i n i t y gel A m or C h (2 ml) w a s p a c k e d in a g l a s s t u b e (0.7 x i0 cm) a n d e q u i l i b r a t e d w i t h w a s h i n g b u f f e r (20 m M T r i s pH 8, 0.3 M NaCI, 1 m M DTT). A crude soluble protein fraction c o n t a i n i n g R S B P e x t r a c t e d f r o m c u l t u r e d H L - 6 0 c e l l s as d e s c r i b e d a b o v e w a s a p p l i e d on the p a c k e d a f f i n i t y gel c o l u m n w i t h a f l o w rate o f 9 ml/h. T h e n the c o l u m n w a s w a s h e d w i t h 50 ml of the washing buffer (9 ml/h). R S B P a b s o r b e d o n the gel w a s e l u t e d with elution buffer (20 m M Tris pH8, 1 m M DTT) a l o n e or the elution buffer containing 20 m M A m 8 0 (g m l / h ) . The e l u e n t w a s applied on a Mono Q HR5/5 column (obtained from Pharmacia) and eluted with a linear gradient of 0 - 0 . 5 M N a C I in the e l u t i o n b u f f e r as d e s c r i b e d p r e v i o u s l y . '4~ R S B P was e l u t e d w i t h 0 . 2 0 - 0 . 2 5 M NaCI in the e l u t i o n b u f f e r . The a m o u n t s of p r o t e i n a n d R S B P were estimated b y the C o o m a s s i e blue method as d e s c r i b e d by B r a d f o r d TM a n d b y f i l t e r b i n d i n g assay, ~4' r e s p e c t i v e l y .
Results
and Discussion It
receptor action.
is
essential
to
elucidate
isolate
the
to
for the
purify
RSBP.
and
molecular
As w e h a d e s t a b l i s h e d
fies the c r i t e r i a started
to
characterize mechanism
the p r e s e n c e
retinoid For
506
receptor this
the of
retinoid
retinoidal
of RSBP,
which
in H L - 6 0
cells, ~4~
we
designed
the
purpose,
we
satis-
VOI. 155, No. 1, 1988
affinity
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
gels with
retinoidal
ligands
(Gel-Am
a n d Gel-Ch)
as
shown
in Fig.2. Fig. obtain
1
to a g a r o s e
10,
gels,
attached
absorb
was
the
360
ability
prepared
than
7.4,
pmole
recovered
of
of anion
ionic to
between
interaction.
of
2
of
was in
shown). 14~ Ch55 than
on
at
300-fold
a and
the
exchange 72
hr
for
affinity
column
purified
more
retinoid-binding protein
fraction
and
needed
not the
Q
HR5/5
Methods.
fraction
or absence
reaction the
is
and
4000-fold
activity (Table
I).
of
incubated
Q
with
the
about
8%
the
buffer low; of of
150 RSBP the
probably
enough
RSBP
to e l u t e
RSBP-Am80
complex
as
described
showed complex
with
only
one
(data
not
3H-Am80
amount
4 ~
a
it
took
plateau.
chromatography, total from
recovery the
o r 3H-
of Ch55.
, and
reach
A quantitative
the
inter-
salt was
pmole
(Pharmacia)
Mono
of
eluted with elution
Eluted
to
the
I.
also
at
passed
conditions),
RSBP-Am80
slow
RSBP
that
(25-30%,
30 ml w a s
binding
that
recovery
dilute
of an e x c e s s
507
60
the
chromatogram
of
was
very
specific
(Gel-Am) than
The time
the the
In a d d i t i o n ,
low
elute
column
in
overwhelming
with
to
7.2,
hydrophobic
excellent
than
high
corresponding
efficiency
in T a b l e
the
rather
efficiency
a
RSBP,
to
very
(less
the
to RSBP.
Though
quite
sufficient
suggests
to
eluted
as s h o w n
retention
The pooled
was
fraction
is
o n the gels w a s
Mono
in the p r e s e n c e
ligand
of was
when
at pH 6.8,
binding
on 2 ml o f the gels).
Materials peak
the
be
was
20 m M A m 8 0
absorbed
possess
to b e l o w
This
there
gels.
under
absorbed
the
the e l u t i o n
was
the
activity
containing
the
major
of
about
separated
could
buffer
ml
The R S B P
the R S B P
ligands
described
adjusted
in
ligands
though
denaturation
purified
buffer
RSBP
alone,
retinoid-binding
was
the
efficiently
to b i n d
that
the r e t i n o i d a l
elution on
because
absorption
Gel-Ch)
ligands
diminished
suggests
absorbed
the
of
conditions
absorption.
retinoidal
also
ionic
absorbed
UV
R S B P was d i m i n i s h e d ;
f o r m is e s s e n t i a l
action
buffer)
the
quantitatively
which
and
RSBP very
the pH was
without
strength
The
(Gel-Am
under
When
the
RSBP,
(elution
to
attached
e s t e r of a g a r o s e
the
O n e ml of the g e l s w a s
to a b s o r b
column
ionization
low
employed
were
the salt c o n c e n t r a t i o n
RSBP
almost
the
gels
From
5-i0~ mole
absorbed
and
and Methods.
carboxylate
ml
that
gels
They
of the gel
through
routes
ligands
N-hydroxysuccinimide
t h a n 0.3 M for N a C I ) .
Materials
These
Laboratories).
estimated
properties. higher
(more
synthetic
1 ml of the gel.
Both
pH w a s
was
the
3 a n d 7.
with
Bio-Rad
it to
similar
shows
ligands
by coupling
(Affi-Gel the
briefly
the a f f i n i t y
crude
consideration
The more By
RSBP
was
of
the
soluble suggests
Vol. 155, No. 1, 1988
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Table I. Purification of RSBP in Crude Soluble Protein Fraction Extracted from HL-60 Cells Loaded Sample Protein RSBP (mg) (pmole)
Columns
Eluted Fraction Protein RSBP Yield (mg) (pmole) (%)
Purification (-fold)
Gel-Am a)
106.0
21.20
0.112
6.36
30
284
Gel-Ch ~
99.0
17.82
0.078
4.63
26
329
Gel-Am ~ / Mono Q
102.0
14.79
0.002
1.26
8.5
4345
Gel-Ch~) /
104.0
15.20
0.001
1.18
7.8
8108
Mono Q
a) RSBP absorbed on the gels was eluted with elution buffer alone. b) RSBP absorbed on the gel was eluted with elution buffer containing 20 mM Am80, and then separated on a Mono Q column.
that
another
sufficient In
step
of
to
for the p u r i f i c a t i o n conclusion,
affinity
were
designed
tive
for the p u r i f i c a t i o n
affinity
10-
gels
a n d prepared. and
50-fold of R S B P gels
for
The gels
of RSBP.
a M o n o Q column,
purification
would
be
to h o m o g e n e i t y . the
were
purification
confirmed
of
RSBP
to be e f f e c -
By the u s e of the p r e p a r e d RSBP
could
be p u r i f i e d
4000-
to
8000-fold. References i) "The R e t i n o i d s , " (1984), ed. M.B.Sporn, A . B . R o b e r t s and D.S. Goodmann, A c a d e m i c Press, Orlando. 2) C I B A F o u n d a t i o n S y m p o s i u m 113, "Retinoids, d i f f e r e n t i a t i o n and d i s e a s e , " (1985), Pitman, Avon. 3) M . B . S p o r n , A . B . R o b e r t s , N.S.Roche, H . K a g e c h i k a and K.Shudo. (1986), J . A m e r . A c a d . Dermato., 15, 756-764. 4) Y . H a s h i m o t o , H . K a g e c h i k a , E , K a w a c h i and K.Shudo. (1986), Jpn. J . C a n c e r Chemother., 13, 3392-3400. 5) H . K a g e c h i k a , E,Kawachi, Y . H a s h i m o t o and K.Shudo. (1984), Chem. P h a r m . B u l l . , 32, 4209-4212. 6) K.Shudo, H . K a g e c h i k a , E . K a w a c h i and Y . H a s h i m o t o . (1985), Chem. P h a r m . B u l l . , 33, 404-407, 7) H . K a g e c h i k a , E.Kawachi, Y . H a s h i m o t o and K . S h u d o . (1985), Chem. Pharm. Bull., 33, 5597-5600. 8) H . K a g e c h i k a , E.Kawachi, Y . H a s h i m o t o and K.Shudo. (1986), Chem. Pharm. Bull., 34, 2275-2278. 9) A . M . J e t t e n , K . A n d e r s o n , M . A . D e a s , H . K a g e c h i k a , R.Lotan, J.I. R e a r i c k a n d K.Shudo. (1987), C a n c e r Res., 47, 3523-3527. i0) K.Takagi, M . S u g a n u m a , H . K a g e c h i k a , K.Shudo, M . N i n o m i y a , Y . M u t o and H.Fujiki. (1988), J . C a n c e r R e s . C l i n . Oncol., in press. ii) M.Sato, K . S h u d o and A . H i r a g u n . (1988), J.Cell Physiol., 135, i-i0. 12) D . D o u e r a n d H . P . K o e f f l e r . (1982), J . C l i n . l n v e s t . , 69, 279-283. 13) T . B r e i t m a n , S . S e l o n i c k a n d S.Collins. (1980), P r o c . N a t l . A c a d . Sci.USA., 77, 2936-2940. 14) Y . H a s h i m o t o , H . K a g e c h i k a , E . K a w a c h i and K.Shudo. (1988), Jpn. J . C a n c e r R e s . ( G a n n ) . , 79, 000-000. 15) M . P e t k o v i c h , N.J.Brand, A . K r u s t and P . C h a m b o n . (1987), Nature, 330, 444-450. 16) N.Brand, M . P e t k o v i c h , A.Krust, P.Chambon, H.deThe, A . M a r c h i o , P . T i o l l a i s and A . D e 3 e a n . (1988), Nature, 332, 850-853. 17) V.Giguere, E.S.Ong, P . S e g u i and R . M . E v a n s . (1987), Nature, 330, 624-629. 18) M . B r a d f o r d . (1976), A n a l . S i o c h e m . , 72, 248-254.
508